The
Tritanium
Family
®
Built with Tritanium In-Growth Technology
1
Introducing
Tritanium TL
Curved Posterior Lumbar Cage
Tritanium C
Anterior Cervical Cage
Tritanium PL
Posterior Lumbar Cage
Osteoblasts
Tritanium In-Growth Technology
For more information, visit us at booth #1401 at the 2018 NASS Annual Meeting
Normal human osteoblast cells were used for in‑vitro cell studies. No correlation to human clinical outcomes has been demonstrated or established.
RD0000053710 | Tritanium cell infiltration and attachment experiment
A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that
surgeons be trained in the use of any particular product before using it in surgery.
The information presented is intended to demonstrate the breadth of Stryker product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any Stryker product. The
products depicted are CE marked according to the Medical Device Directive 93/42/EEC. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual
markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.
1. PROJ 43909 | Tritanium technology claim support memo
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker, Tritanium. All other trademarks are trademarks of their respective owners
or holders.
TRITA-TG-17_17233